The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel and selective oral PI3Kα/δ inhibitor, TQ-B3525, in patients with relapsed and/or refractory follicular lymphoma: A phase II, single-arm, open-label study.
 
Huaqing Wang
No Relationships to Disclose
 
Aibin Liang
No Relationships to Disclose
 
Jifeng Feng
No Relationships to Disclose
 
YANYAN LIU
No Relationships to Disclose
 
Zhengzi Qian
No Relationships to Disclose
 
Da Gao
No Relationships to Disclose
 
Xuehong Ran
No Relationships to Disclose
 
Hui Zhou
No Relationships to Disclose
 
Lihong Liu
No Relationships to Disclose
 
Binghua Wang
No Relationships to Disclose
 
Meiyun Fang
No Relationships to Disclose
 
Hebing Zhou
No Relationships to Disclose
 
Zhenqian Huang
No Relationships to Disclose
 
Shi Tao
No Relationships to Disclose
 
Zhuowen Chen
No Relationships to Disclose
 
Liping Su
No Relationships to Disclose
 
Hang Su
No Relationships to Disclose
 
Yu Yang
No Relationships to Disclose
 
Xiaobao Xie
No Relationships to Disclose
 
Zhiming Li
No Relationships to Disclose